The German government will fund the development of a nasal vaccine against COVID-19 that is similar to the flu vaccine already used for children, Trends reported, citing Xinhua.
Education and Research Minister Bettina Stark-Watzinger told Augsburg Zeitung on Thursday that since the vaccine is applied directly to the nasal mucosa using a spray, it will “become a It takes effect where it enters the human body.”
According to Stark-Watzinger, research projects at the Munich University Hospital will receive nearly 1.7 million euros ($1.73 million) in funding from the country’s Ministry of Education and Research (BMBF).
Project leader Josef Rosenecker explained that the vaccine can be administered without needles and is therefore painless.It can also be administered without the need for medical staff.These factors may make it easier for patients to receive the vaccine, Stark-Watzinger said.
Of the 69.4 million adults aged 18 and over in Germany, about 85% have been vaccinated against COVID-19.Official figures show that nearly 72% of people have received one booster, while nearly 10% have received two boosters.
On trains and in certain indoor areas such as hospitals, according to the country’s new draft infection protection law jointly submitted by the Ministry of Health (BMG) and the Ministry of Justice (BMJ) on Wednesday.
The country’s federal states will be allowed to take more comprehensive measures, which could include mandatory testing in public institutions such as schools and nurseries.
“In contrast to previous years, Germany should prepare for the next COVID-19 winter,” Health Minister Karl Lauterbach said when introducing the draft.(1 EUR = 1.02 USD)
Post time: Aug-05-2022